Top

World Journal of Urology

Published in:

01-12-2012 | Letter to Editor

First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival

Authors: Wolfgang Otto, Stefan Denzinger, Wolf F. Wieland, Arndt Hartmann

Published in: World Journal of Urology | Issue 6/2012

Excerpt

Dear editor …

Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(5795):1960–1964PubMedCrossRef

Fridman WH, Galon J, Pagès F, Tartour E, Sautès-Fridman C, Kroemer G (2011) Prognostic and predictive impact of intra- and peritumoral immune infiltrates. Cancer Res 71(17):5601–5605PubMedCrossRef

Hilmy M, Campbell R, Bartlett JM, McNicol AM, Underwood MA, McMillan DC (2006) The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder. Br J Cancer 95(9):1234–1238PubMedCrossRef

Winerdal ME, Marits P, Winerdal M, Hasan M, Rosenblatt R, Tolf A, Selling K, Sherif A, Winqvist O (2011) FOXP3 and survival in urinary bladder cancer. BJU Int 108(10):1672–1678PubMedCrossRef

van den Bosch S, Alfred Witjes J (2011) Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review. Eur Urol 60(3):493–500PubMedCrossRef

Title: First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival
Authors: Wolfgang Otto
Stefan Denzinger
Wolf F. Wieland
Arndt Hartmann
Publication date: 01-12-2012
Publisher: Springer-Verlag
Published in: World Journal of Urology / Issue 6/2012
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-012-0974-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2012

Radical cystectomy in patients over 70 years of age: impact of comorbidity on perioperative morbidity and mortality

Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy

Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?

Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy

The impact of signet-ring cell carcinoma histology on bladder cancer outcome

The ileal neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome